A short Scale for Evaluation of Neuropsychiatric Disorders in Parkinson's Disease: First psychometric approach

Journal of Neurology

Volumn 259, Issue 11, 2012, Pages 2299-2308

  Martinez Martin, Pablo ^a,b   Frades Payo, Belen ^a,b   Agüera Ortiz, Luis ^a,b,c   Ayuga Martinez, Angel ^d  

^a Instituto de Salud Carlos III   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d UCB PHARMA   (Belgium)

Author keywords

Neuropsychiatric symptoms; Parkinson's disease; Rating scale; Severity; Validity

Indexed keywords

ACCURACY; ADULT; AGED; APATHY; ARTICLE; CAREGIVER; CLINICAL EVALUATION; CLINICAL IMPRESSION OF SEVERITY INDEX; CROSS-SECTIONAL STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HOEHN AND YAHR STAGING; HUMAN; IMPULSE CONTROL DISORDER; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; MOOD; MULTICENTER STUDY; OBSERVATIONAL STUDY; PARKINSON DISEASE; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOSIS; RATING SCALE; SCALES FOR OUTCOME IN PARKINSON DISEASE MOTOR AND PSYCHIATRIC COMPLICATION; ZARIT CAREGIVER BURDEN INVENTORY;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHOMETRICS; SEVERITY OF ILLNESS INDEX;

EID: 84868214292     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6490-x     Document Type: Article

References (65)

1. Lees AJ, Hardy J, Revesz T (2009) Parkinson's disease. Lancet 373:2055-2066
2. Chaudhuri KR, Healy DG, Schapira AHV (2006) Non-motor symptoms in Parkinson's disease: diagnosis and management. Lancet Neurol 5:235-245 (Pubitemid 43238347)
3. Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, MacPhee G et al (2007) Prevalence of nonmotor symptoms in Parkinson's disease in an international setting: Study using non-motor symptoms questionnaire in 545 patients. Mov Disord 22:1623-1629 (Pubitemid 47477925)
4. Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Ray Chaudhuri K, on behalf of the NMSS Validation Group (2011) The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Mov Disord 26:399-406
5. Park A, Stacy M (2011) Dopamine-induced nonmotor symptoms of Parkinson's Disease. Parkinson Dis. doi:10.4061/2011/485063
6. Chaudhuri KR, Schapira AHV (2009) Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464-474
7. Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P et al (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 21:916-923 (Pubitemid 44184590)
8. Krishnan S, Sarma G, Sarma S, Kishore A (2011) Do nonmotor symptoms in Parkinson's disease differ from normal aging? Mov Disord 26:2110-2113
9. Papapetropoulos S, Mash DC (2005) Psychotic symptoms in Parkinson's disease. From description to etiology. J Neurol 252:753-764 (Pubitemid 40984849)
10. Weintraub D, Burn DJ (2011) Parkinson's Disease: the quintessential neuropsychiatric disorder. Mov Disord 26:1022-1031
11. Friedberg G, Zoldan J, Weizman A, Melamed E (1998) Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease. Clin Neuropharmacol 21:280-284 (Pubitemid 28491427)
12. Brandstaedter D, Spieker S, Ulm G, Siebert U, Eichhorn TE, Krieg JC et al (2005) Development and evaluation of the Parkinson Psychosis Questionnaire: a screening-instrument for the early diagnosis of drug-induced psychosis in Parkinson's disease. J Neurol 252:1060-1066 (Pubitemid 41355836)
13. Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P et al (2007) The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 22:1901-1911 (Pubitemid 350134203)
14. Visser M, Verbaan D, van Rooden SM, Stiggelbout AM, Marinus J, Van Hilten JJ (2007) Assessment of psychiatric complications in Parkinson's disease: the SCOPA-PC. Mov Disord 22:2221-2228
15. Goetz CG, Tilley BC, Shaftman SR, Stebbins G, Fahn S, Martinez-Martin P et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov Disord 23:2129-2170
16. Ardouin C, Chéreau I, Llorca PM, Lhommée E, Durif F, Pollak P et al (2009) Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease. Rev Neurol (Paris) 165:845-856 (Article in French)
17. Virués-Ortega J, Rodriguez-Blazquez C, Micheli F, Carod-Artal FJ, Serrano-Dueñas M, Martinez-Martin P (2010) Cross-cultural evaluation of the modified Parkinson Psychosis Rating Scale across disease stages. Mov Disord 25:1391-1398
18. Fernandez HH, Aarsland D, Fénelon G, Friedman JH, Marsh L, Tröster AI et al (2008) Scales to assess psychosis in Parkinson's disease: critique and recommendations. Mov Disord 23:484-500
19. Martinez-Martin P, Guerrero Diaz MT, Frades-Payo B (2004) Neuropsychological disorders in Parkinson's disease: evaluating them and their impact on the caregiver. Rev Neurol 39:639-645 (Article in Spanish) (Pubitemid 40576007)
20. Martínez-Martín P, Forjaz MJ, Frades-Payo B, Bayes-Rusiñol A, Fernández-García JM, Benito-León J et al (2007) Caregiver burden in Parkinson's disease. Mov Disord 22:924-931 (Pubitemid 46999286)
21. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17:427-442
22. Marinus J, Visser M, Stiggelbout AM, Martin Rabey J, Martínez- Martín P, Bonuccelli U et al (2004) A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry 75:388-395 (Pubitemid 38338767)
23. Martínez-Martín P, Benito-León J, Burguera JA, Castro A, Linazasoro G, Martínez-Castrillo JC et al (2005) The SCOPA-Motor Scale for assessment of Parkinson's disease is a consistent and valid measure. J Clin Epidemiol 58:674-679 (Pubitemid 40797897)
24. Martinez-Martin P, Forjaz MJ, Cubo E, Frades B, de Pedro Cuesta J, ELEP Project Members (2006) Global versus factor-related impression of severity in Parkinson's disease: a new clinimetric index (CISI-PD). Mov Disord 21:208-214
25. Martinez-Martin P, Rodriguez-Blazquez C C, Forjaz MJ, de Pedro J, on behalf of the Spanish-American Longitudinal PD Patient Study Group (2009) The Clinical Impression of Severity Index for Parkinson's Disease: international validation study. Mov Disord 24:211-217
26. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
27. Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA et al (2007) Diagnostic procedures for Parkinson's disease dementia: recommendations from the Movement Disorder Society task force. Mov Disord 22:2314-2324 (Pubitemid 351155975)
28. Zarit SH, Reever KE, Bach-Peterson J (1980) Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 20:649-655 (Pubitemid 11170845)
29. Overall JE, Gorham DR (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10:799-812
30. Sultzer DL, Levin HS, Mahler ME, High WM, Cummings JL (1992) Assessment of cognitive, psychiatric, and behavioral disturbances in patients with dementia: the Neurobehavioral Rating Scale. J Am Geriatr Soc 40:549-555
31. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308-2314 (Pubitemid 24382728)
32. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 25:2649-2653
33. McHorney CA, Tarlov AR (1995) Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 4:293-307
34. Hays RD, Anderson R, Revicki D (1993) Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 2:441-449 (Pubitemid 24035216)
35. Smith SC, Lamping DL, Banarjee S, Harwood R, Foley B, Smith P et al (2005) Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. Health Technol Assess 9:16-19
36. Scientific Advisory Committee of the Medical Outcomes Trust (2002) Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 11:193-205
37. van der Linden FA, Kragt JJ, Klein M, van der Ploeg HM, Polman CH, Uitdehaag BM (2005) Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use. J Neurol Neurosurg Psychiatry 76:1677-1681 (Pubitemid 41697633)
38. Eisen M, Ware JE Jr, Donald CA, Brook RH (1979) Measuring components of children's health status. Med Care 17:902-921 (Pubitemid 10247183)
39. Juniper EF, Guyatt GH, Jaeschke R (1996) How to develop and validate a new health-related quality of life instrument. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials, 2nd edn. Lippincott-Raven Publishers, Philadelphia, pp 49-56
40. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc 57:289-300
41. Beaton DE, Bombardier C, Katz JN, Wright JG (2001) A taxonomy for responsiveness. J Clin Epidemiol 54:1204-1217 (Pubitemid 34002973)
42. de Vet HC, Terwee CB, Ostelo RW, Beckerman H, Knol DL, Bouter LM (2006) Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change. Health Qual Life Outcomes 4:54
43. Shulman LM, Taback RL, Rabinstein AA, Weiner WJ (2002) Nonrecognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 8:193-197 (Pubitemid 33091403)
44. Goetz CG, Leurgans S, Pappert EJ, Raman R, Stemer AB (2001) Prospective longitudinal assessment of hallucinations in Parkinson's disease. Neurology 57:2078-2082 (Pubitemid 33126877)
45. Ondo WG, Tintner R, Dat Voung K, Lai D, Ringholz G (2005) Double-blind, placebo-controlled, unforced titration, parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease. Mov Disord 20:958-963 (Pubitemid 41419510)
46. Schrag A, Barone P, Brown RG, Leentjens AFG, McDonald WM, Starkstein S et al (2007) Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord 22:1077-1092 (Pubitemid 47067217)
47. Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE et al (2008) Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations. Mov Disord 23:2004-2014
48. Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE et al (2008) Anxiety rating scales in Parkinson's disease: critique and recommendations. Mov Disord 23:2015-2025
49. de Boer AG, Wijker W, Speelman JD, de Haes JCJM (1996) Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 61:70-74 (Pubitemid 26232031)
50. Martinez-Martin P, Cubo E (2007) Scales to measure parkinsonism. In: Koller WC, Melamed E (eds) Handbook of Clinical Neurology: Parkinson's Disease and Related Disorders, Part I, vol 83., 3rd seriesElsevier, Edinburgh, pp 291-327
51. Martínez-Martín P, Benito-León J, Alonso F, Catalán MJ, Pondal M, Zamarbide I (2004) Health-related quality of life evaluation by proxy in Parkinson's disease: approach using PDQ-8 and EuroQoL-5D. Mov Disord 19:312-318 (Pubitemid 38961086)
52. Mack J, Rabins P, Anderson K, Goldstein S, Grill S, Hirsch ES et al (2011) Prevalence of psychotic symptoms in a community-based Parkinson Disease sample. Am J Geriatr Psychiatry. PMID:21617521
53. Evans AH, Katzenschlager R, Paviour D, O'Sullivan JD, Appel S, Lawrence AD et al (2004) Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397-405 (Pubitemid 38559642)
54. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V et al (2010) Impulse control disorders in Parkinson's disease. Arch Neurol 67:589-595
55. Djamshidian A, Cardoso F, Grosset D, Bowden-Jones H, Lees AJ (2011) Pathological gambling in Parkinson's disease - a review of the literature. Mov Disord 26:1976-1984
56. Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJL (2000) Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423-428 (Pubitemid 30248740)
57. Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE et al (2006) Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 63:969-973 (Pubitemid 44036299)
58. Huang C, Mattis P, Tang C, Perrine K, Carbon M, Eidelberg D (2007) Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage 34:714-723 (Pubitemid 44827754)
59. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 22:1689-1707 (Pubitemid 47597592)
60. Martinez-Martin P, Falup-Pecurariu C, Rodriguez-Blazquez C, Serrano-Dueñas M, Carod Artal FJ, Rojo-Abuin JM, Aarsland D (2011) Dementia associated with Parkinson's Disease: applying the Movement Disorder Society Task Force criteria. Parkinson-ism Rel Disord 17:621-624
61. Poewe W (2003) Psychosis in Parkinson's Disease. Mov Disord 18(Suppl 6):S80-S87 (Pubitemid 37185200)
62. Weintraub D, Stern MB (2005) Psychiatric complications in Parkinson disease. Am J Geriatr Psychiatry 13:844-851 (Pubitemid 46638672)
63. Wyrwich KW, Tierney WM, Wolinsky FD (1999) Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 52:861-873 (Pubitemid 29385600)
64. Terwee CB, Roorda LD, Knol DL, De Boer MR, De Vet HCW (2009) Linking measurement error to minimal important change of patient-reported outcomes. J Clin Epidemiol 62:1062-1067
65. Beckerman H, Roebroeck ME, Lankhorst GJ, Becher JG, Bezemer PD, Verbeek ALM (2001) Smallest real difference, a link between reproducibility and responsiveness. Qual Life Res 10:571-578 (Pubitemid 34056327)